Question:

What types of tests will be impacted by lab reimbursement cuts if these cuts are finalized for next year?

Answer:

According to the American Clinical Laboratory Association (ACLA), over 800 tests across the nation are slated to experience an up to 15 percent reimbursement cut at the start of the next year. However, this is the shadow of “previous rounds of cuts between 2017 and 2022 that resulted in payment for tests used to screen and diagnose diabetes, heart disease, and other chronic conditions to be cut by 27 percent. Some tests could see a cumulative cut of up to 41 percent.” In particular, cuts may reduce access to lab services specifically responsible for senior care with the ACLA naming several key conditions that may be impacted including:

  • diabetes
  • heart disease
  • liver disease
  • kidney disease
  • prostate and colon cancers
  • anemia
  • viral and bacterial infections
  • opioid dependency.

The ACLA draws some stark conclusions on the implications of more payment cuts: “Without congressional intervention this year, laboratories across the country will face tough decisions potentially reducing services offered to patients and curbing investment in the next generation of diagnostic tests.”

This question was answered in an edition of our Laboratory Compliance Manager. For more hot topics relating to laboratory services, please visit our store or call us at 1.800.252.1578, ext. 2.

Facebook
Twitter
LinkedIn
Email
Print

CPT® copyright 2021 American Medical Association (AMA). All rights reserved.

Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.

CPT is a registered trademark of the American Medical Association.